US Stock MarketDetailed Quotes

ASMB Assembly Biosciences

Watchlist
  • 15.040
  • +0.320+2.17%
Close Nov 22 16:00 ET
  • 15.040
  • 0.0000.00%
Post 20:02 ET
95.60MMarket Cap-2182P/E (TTM)

Assembly Biosciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
6.85M
8.53M
5.79M
7.16M
7.16M
0
0
0
0
0
Operating revenue
--6.85M
--8.53M
--5.79M
--7.16M
--7.16M
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
18.29%17.8M
18.57%20.74M
-15.57%16.51M
-23.70%71.81M
-14.20%19.71M
-35.70%15.05M
-28.83%17.49M
-15.56%19.56M
-3.28%94.11M
8.13%22.98M
Selling and administrative expenses
1.47%4.29M
-9.83%4.48M
-7.52%4.64M
-5.08%22.91M
42.17%8.71M
-19.86%4.22M
-26.78%4.97M
-15.86%5.01M
-16.14%24.13M
-5.83%6.13M
-General and administrative expense
1.47%4.29M
-9.83%4.48M
-7.52%4.64M
-5.08%22.91M
42.17%8.71M
-19.86%4.22M
-26.78%4.97M
-15.86%5.01M
-16.14%24.13M
-5.83%6.13M
Research and development costs
24.86%13.52M
29.83%16.26M
-18.34%11.88M
-30.12%48.9M
-34.69%11.01M
-40.30%10.82M
-29.61%12.52M
-15.45%14.55M
2.12%69.98M
14.28%16.85M
Operating profit
27.19%-10.96M
30.22%-12.2M
45.15%-10.73M
31.31%-64.65M
45.38%-12.55M
35.70%-15.05M
28.83%-17.49M
15.56%-19.56M
-3.37%-94.11M
-8.13%-22.98M
Net non-operating interest income expense
113.85%1.34M
146.11%1.46M
171.26%1.65M
237.67%3.45M
178.22%1.62M
145.31%628K
428.57%592K
757.75%609K
238.41%1.02M
477.23%583K
Non-operating interest income
113.85%1.34M
146.11%1.46M
171.26%1.65M
237.67%3.45M
178.22%1.62M
145.31%628K
428.57%592K
757.75%609K
238.41%1.02M
477.23%583K
Other net income (expense)
Income before tax
33.34%-9.61M
36.40%-10.75M
52.10%-9.08M
34.26%-61.2M
51.20%-10.93M
37.70%-14.42M
30.93%-16.9M
17.93%-18.95M
29.68%-93.09M
64.33%-22.4M
Income tax
0
406K
33K
33K
0
0
0
Net income
33.34%-9.61M
34.00%-11.15M
52.10%-9.08M
34.23%-61.23M
51.05%-10.96M
37.70%-14.42M
30.93%-16.9M
17.93%-18.95M
28.31%-93.09M
62.83%-22.4M
Net income continuous Operations
33.34%-9.61M
34.00%-11.15M
52.10%-9.08M
34.23%-61.23M
51.05%-10.96M
37.70%-14.42M
30.93%-16.9M
17.93%-18.95M
28.31%-93.09M
62.83%-22.4M
Minority interest income
Net income attributable to the parent company
33.34%-9.61M
34.00%-11.15M
52.10%-9.08M
34.23%-61.23M
51.05%-10.96M
37.70%-14.42M
30.93%-16.9M
17.93%-18.95M
28.31%-93.09M
62.83%-22.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
33.34%-9.61M
34.00%-11.15M
52.10%-9.08M
34.23%-61.23M
51.05%-10.96M
37.70%-14.42M
30.93%-16.9M
17.93%-18.95M
28.31%-93.09M
62.83%-22.4M
Basic earnings per share
54.10%-1.51
48.97%-1.98
62.78%-1.66
42.03%-13.38
68.17%-1.77
42.88%-3.29
36.60%-3.88
22.57%-4.46
35.89%-23.08
66.18%-5.56
Diluted earnings per share
54.10%-1.51
48.97%-1.98
62.78%-1.66
42.03%-13.38
68.17%-1.77
42.88%-3.29
36.60%-3.88
22.57%-4.46
35.89%-23.08
66.18%-5.56
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 6.85M8.53M5.79M7.16M7.16M00000
Operating revenue --6.85M--8.53M--5.79M--7.16M--7.16M--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 18.29%17.8M18.57%20.74M-15.57%16.51M-23.70%71.81M-14.20%19.71M-35.70%15.05M-28.83%17.49M-15.56%19.56M-3.28%94.11M8.13%22.98M
Selling and administrative expenses 1.47%4.29M-9.83%4.48M-7.52%4.64M-5.08%22.91M42.17%8.71M-19.86%4.22M-26.78%4.97M-15.86%5.01M-16.14%24.13M-5.83%6.13M
-General and administrative expense 1.47%4.29M-9.83%4.48M-7.52%4.64M-5.08%22.91M42.17%8.71M-19.86%4.22M-26.78%4.97M-15.86%5.01M-16.14%24.13M-5.83%6.13M
Research and development costs 24.86%13.52M29.83%16.26M-18.34%11.88M-30.12%48.9M-34.69%11.01M-40.30%10.82M-29.61%12.52M-15.45%14.55M2.12%69.98M14.28%16.85M
Operating profit 27.19%-10.96M30.22%-12.2M45.15%-10.73M31.31%-64.65M45.38%-12.55M35.70%-15.05M28.83%-17.49M15.56%-19.56M-3.37%-94.11M-8.13%-22.98M
Net non-operating interest income expense 113.85%1.34M146.11%1.46M171.26%1.65M237.67%3.45M178.22%1.62M145.31%628K428.57%592K757.75%609K238.41%1.02M477.23%583K
Non-operating interest income 113.85%1.34M146.11%1.46M171.26%1.65M237.67%3.45M178.22%1.62M145.31%628K428.57%592K757.75%609K238.41%1.02M477.23%583K
Other net income (expense)
Income before tax 33.34%-9.61M36.40%-10.75M52.10%-9.08M34.26%-61.2M51.20%-10.93M37.70%-14.42M30.93%-16.9M17.93%-18.95M29.68%-93.09M64.33%-22.4M
Income tax 0406K33K33K000
Net income 33.34%-9.61M34.00%-11.15M52.10%-9.08M34.23%-61.23M51.05%-10.96M37.70%-14.42M30.93%-16.9M17.93%-18.95M28.31%-93.09M62.83%-22.4M
Net income continuous Operations 33.34%-9.61M34.00%-11.15M52.10%-9.08M34.23%-61.23M51.05%-10.96M37.70%-14.42M30.93%-16.9M17.93%-18.95M28.31%-93.09M62.83%-22.4M
Minority interest income
Net income attributable to the parent company 33.34%-9.61M34.00%-11.15M52.10%-9.08M34.23%-61.23M51.05%-10.96M37.70%-14.42M30.93%-16.9M17.93%-18.95M28.31%-93.09M62.83%-22.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 33.34%-9.61M34.00%-11.15M52.10%-9.08M34.23%-61.23M51.05%-10.96M37.70%-14.42M30.93%-16.9M17.93%-18.95M28.31%-93.09M62.83%-22.4M
Basic earnings per share 54.10%-1.5148.97%-1.9862.78%-1.6642.03%-13.3868.17%-1.7742.88%-3.2936.60%-3.8822.57%-4.4635.89%-23.0866.18%-5.56
Diluted earnings per share 54.10%-1.5148.97%-1.9862.78%-1.6642.03%-13.3868.17%-1.7742.88%-3.2936.60%-3.8822.57%-4.4635.89%-23.0866.18%-5.56
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data